KYTHERA BIOPHARMACEUTICALS INC 4

4 · KYTHERA BIOPHARMACEUTICALS INC · Filed Sep 24, 2015

Form 4

Period: 2015-09-23

General Counsel

Transactions

Exercise/Conversion
Common Stock
2015-09-23$8.22/sh+14,203$116,749→ 18,271 total
Sale
Common Stock
2015-09-23$74.90/sh−26,800$2,007,320→ 4,068 total
Exercise/Conversion
Stock Options
2015-09-23−14,203→ 0 total
Exercise: $8.22Exp: 2022-02-01→ Common Stock (14,203 underlying)
Exercise/Conversion
Stock Options
2015-09-23−11,150→ 15,608 total
Exercise: $44.02Exp: 2024-01-22→ Common Stock (11,150 underlying)
Exercise/Conversion
Common Stock
2015-09-23$27.50/sh+26,800$737,000→ 30,848 total
Sale
Common Stock
2015-09-23$74.90/sh−14,203$1,063,805→ 4,068 total
Exercise/Conversion
Common Stock
2015-09-23$44.02/sh+11,150$490,823→ 15,198 total
Sale
Common Stock
2015-09-23$74.90/sh−11,150$835,135→ 4,068 total
Exercise/Conversion
Stock Options
2015-09-23−13,400→ 0 total
Exercise: $27.50Exp: 2023-01-29→ Common Stock (13,400 underlying)

Footnotes (2)

[F1]The shares subject to these options vested 100% upon the achievement of certain performance milestones approved by the Issuer's Board of Directors.
[F2]25% of the shares subject to the option vested on the first anniversary measured from January 1, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Documents

1 file